Gentamicin Sulfate: Clinical Trials

10 trials of Gentamicin Sulfate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 unknown, 1 recruiting. 8 Phase 2, 4 Phase 1, 2 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Completed 5, Unknown 2, Recruiting 1
Phase 14Completed 2, Recruiting 1, Unknown 1
Phase 32Completed 2
Early Phase 11Completed 1

Follow Gentamicin Sulfate: new trials by email Literature Review of Gentamicin Sulfate trials Research Report on Gentamicin Sulfate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical Gentamicin Nonsense Suppression Therapy of EB
Gentamicin Sulfate - Epidermolysis Bullosa
Phase 1 / Phase 2CompletedOslo University Hospital42020-12-012022-05-03
Gentamicin Intravesical Efficacy for Infection of Urinary Tract
gentamicin sulfate, Catheter clamping only - Postoperative Urinary Tract Infection, Pelvic Organ Prolapse
Phase 2CompletedKaiser Permanente3702020-01-292022-11-08
A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia
Benzyl penicillin, Gentamicin Sulfate, Ceftriaxone - Pneumonia
Phase 3CompletedUniversity of Oxford43922019-08-192024-07-08
Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections
Gentamicin Sulfate, Placebo instillation (saline alone), No instillation - Neurogenic Bladder, Spinal Cord Injuries
Phase 2CompletedUniversity of Louisville62019-02-192025-01-29
Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury
Gentamicin Sulfate - Urinary Tract Infections, Spinal Cord Injuries
Phase 2 / Phase 3CompletedUniversity of Michigan232018-08-242024-06-25
Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Gentamicin - Recessive Dystrophic Epidermolysis Bullosa
Phase 1 / Phase 2UnknownUniversity of Southern California92018-07-052022-11-03
Gentamicin for Junctional Epidermolysis Bullosa
Gentamicin Sulfate - Junctional Epidermolysis Bullosa
Phase 1 / Phase 2RecruitingUniversity of Southern California62018-06-012020-04-07
Efficacy of Topical Gentamycin for Hereditary Hypotrichosis Simplex Caused by Nonsense Mutations in CDSN
Gentamicin Sulfate - Hereditary Hypotrichosis Simplex
Phase 2UnknownTel-Aviv Sourasky Medical Center82018-04-012018-04-10
Gentamicin for RDEB
Gentamicin Sulfate - Recessive Dystrophic Epidermolysis Bullosa
Phase 1 / Phase 2CompletedUniversity of Southern California62017-02-022019-07-23
Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit
vancomycin or gentamicin, Placebo - Respiratory Infection, Bacterial Resistance
Early Phase 1CompletedStony Brook University472001-12-012013-06-17

Conditions studied

Epidermolysis Bullosa Dystrophica (2)  ·  Spinal Cord Injuries (2)  ·  Urinary Bladder, Neurogenic (2)  ·  Urinary Tract Infections (2)  ·  Epidermolysis Bullosa (1)  ·  Epidermolysis Bullosa, Junctional (1)  ·  Hypotrichosis simplex (1)  ·  Pelvic Organ Prolapse (1)  ·  Pneumonia (1)  ·  Pneumonia, Ventilator-Associated (1)  ·  Respiratory Insufficiency (1)  ·  Respiratory Tract Infections (1)  ·  Spinal Cord Diseases (1)  ·  Urinary Incontinence, Stress (1)

Sponsors

University of Southern California (3)  ·  Kaiser Permanente (1)  ·  Oslo University Hospital (1)  ·  Stony Brook University (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  University of Louisville (1)  ·  University of Michigan (1)  ·  University of Oxford (1)

Countries

United States (7)  ·  Kenya (1)  ·  Norway (1)

Top investigators

Ambrose Agweyu, PhD (1)  ·  Anne Pelletier-Cameron, MD (1)  ·  David T. Woodley, MD (1)  ·  David Woodley, MD (1)  ·  Denise G Tate, PhD (1)  ·  Kimberly L Ferrante, M.D., M.A.S. (1)  ·  Liat Samuelov (1)  ·  Lucy B Palmer, MD (1)  ·  Marianna Alperin, M.D., M.S. (1)  ·  Mei Chen, Ph.D (1)  ·  Susan Harkema, PhD (1)

Results publications

PMID 24646034, PMID 35234826, PMID 36409639